We were able to validate previous findings describing frequent hypermethylation events of EPHA7, MGMT and MLH1 in colorectal cancer patients, RARB in prostate tumors, and CASP8 in glioblastoma (Supplementary Figure S13). This evidence concerns the gene MLH1 and colorectal cancer.